We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNOV icon
10326
Innovator US Equity Power Buffer ETF November
PNOV
$899M
$228K ﹤0.01%
8,059
-16,260
-67% -$474K
SCPH
10327
DELISTED
scPharmaceuticals
SCPH
$228K ﹤0.01%
47,234
+15,740
+50% +$77.9K
TBLA icon
10328
CALL
Taboola.com
TBLA
$1.09B
$228K ﹤0.01%
90,100
+700
+0.8% +$2.57K
TMC icon
10329
CALL
TMC The Metals Company
TMC
$1.77B
$228K ﹤0.01%
221,100
-196,000
-47% -$303K
ARVN icon
10330
PUT
Arvinas
ARVN
$587M
$227K ﹤0.01%
5,400
-4,300
-44% -$216K
CHIQ icon
10331
PUT
Global X MSCI China Consumer Discretionary ETF
CHIQ
$120M
$227K ﹤0.01%
9,600
-3,000
-24% -$60.1K
EPSN icon
10332
Epsilon Energy
EPSN
$169M
$227K ﹤0.01%
+38,484
New +$262K
FXE icon
10333
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
$227K ﹤0.01%
2,346
-60,243
-96% -$5.94M
PODD icon
10334
Insulet
PODD
$9.94B
$227K ﹤0.01%
1,041
-78,312
-99% -$17.8M
TAC icon
10335
TransAlta
TAC
$4.05B
$227K ﹤0.01%
19,871
-100,887
-84% -$1.11M
CANO
10336
PUT
DELISTED
Cano Health, Inc.
CANO
$227K ﹤0.01%
518
-1,117
-68% -$582K
CRU
10337
PUT
DELISTED
Crucible Acquisition Corporation
CRU
$227K ﹤0.01%
23,100
-126,200
-85% -$1.24M
ARQQ icon
10338
PUT
Arqit Quantum
ARQQ
$424M
$226K ﹤0.01%
1,432
-2,900
-67% -$601K
EET icon
10339
ProShares Ultra MSCI Emerging Markets
EET
$37.2M
$226K ﹤0.01%
4,065
-2,514
-38% -$154K
FFTY icon
10340
CALL
CapForce IBD 50 ETF
FFTY
$81.2M
$226K ﹤0.01%
8,400
+600
+8% +$19.3K
HIBS icon
10341
CALL
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$17.4M
$226K ﹤0.01%
176
-214
-55% -$224K
INDI icon
10342
PUT
indie Semiconductor
INDI
$995M
$226K ﹤0.01%
39,600
+1,600
+4% +$11K
NINE
10343
CALL
DELISTED
Nine Energy Service
NINE
$226K ﹤0.01%
85,200
+6,700
+9% +$20.2K
IMDX
10344
Insight Molecular Diagnostics
IMDX
$141M
$226K ﹤0.01%
12,576
+10,533
+516% +$240K
PDEC icon
10345
Innovator US Equity Power Buffer ETF December
PDEC
$999M
$226K ﹤0.01%
+7,848
New +$233K
REI icon
10346
PUT
Ring Energy
REI
$357M
$226K ﹤0.01%
85,100
-55,600
-40% -$230K
ROM icon
10347
CALL
ProShares Ultra Technology
ROM
$1.32B
$226K ﹤0.01%
7,900
-77,900
-91% -$2.81M
SPSC icon
10348
PUT
SPS Commerce
SPSC
$2.86B
$226K ﹤0.01%
+2,000
New +$226K
TG icon
10349
CALL
Tredegar Corp
TG
$276M
$226K ﹤0.01%
22,600
-800
-3% -$9.28K
EVLO
10350
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$226K ﹤0.01%
5,371
+2,219
+70% +$103K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.